Want to join the conversation?
$UNM's operating revenue for 2015 increased by 2.5% from last year. This rise was driven by combined premium income growth of about 5% in its principal operating business segments. Net investment income, while a significant source of revenue for $UNM, was slightly below the level of the prior year.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.